Is Elevance Health (ELV) Undervalued After Its Recent Share Price Rally?

Elevance Health (ELV) has been on investors’ radar after a recent share price move, with the stock last closing at US$412.70. That shift now meets a business generating US$201.1b in annual revenue. Recent trading has been firm, with a 1-day share price return of 2.93% and a 7-day share price return of 6.80%. Elevance Health’s year-to-date share price return of 16.50% and 1-year total shareholder return of 19.16% point to momentum building despite a small 3-year total shareholder return...